Black Diamond Therapeutics, Inc. Logo

Black Diamond Therapeutics, Inc.

Develops precision oncology therapies targeting families of oncogenic mutations.

BDTX | US

Overview

Corporate Details

ISIN(s):
US09203E1055
LEI:
Country:
United States of America
Address:
ONE MAIN STREET, 14TH FLOOR, 2142 CAMBRIDGE

Description

Black Diamond Therapeutics, Inc. is a clinical-stage precision oncology company developing MasterKey therapies. These therapies are designed to target families of oncogenic mutations in patients with genetically defined cancers. The company's approach aims to provide a single solution for multiple mutations, thereby expanding the addressable patient population. The therapies are engineered to overcome treatment resistance, minimize toxicities related to wild-type proteins, and be brain-penetrant to treat central nervous system diseases. Primary areas of focus include non-small cell lung cancer (NSCLC) and glioblastoma (GBM).

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2024-12-15
English
4.2 MB
2024-10-30
German
1.8 MB
2024-08-14
French
0.5 MB
2024-05-22
English
2.1 MB
2024-03-10
English
3.5 MB
2024-01-15
German
1.2 MB
2023-11-20
English
5.1 MB

Full Filing History Restricted

Access to specific historical documents or filtered results is limited in the Web UI. Request access to the complete dataset.

Automate Your Workflow. Get a real-time feed of all Black Diamond Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Black Diamond Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Black Diamond Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

BioLineRx Ltd. Logo
A clinical-stage biopharmaceutical company developing therapies for oncology and rare diseases.
Israel
BLRX
BIOMARIN PHARMACEUTICAL INC Logo
A global biotechnology company developing therapies for rare, life-threatening genetic diseases.
United States of America
BMRN
BioMaxima S.A. Logo
Manufacturer and distributor of in-vitro diagnostics for clinical microbiology.
Poland
BMX
Biomea Fusion, Inc. Logo
A clinical-stage biopharma developing oral drugs for diabetes and obesity.
United States of America
BMEA
BIOMERICA INC Logo
Develops in-vitro diagnostic and therapeutic products for chronic diseases.
United States of America
BMRA
bioMérieux Logo
A global leader in in vitro diagnostics for clinical and industrial applications.
France
BIM
BiomX Inc. Logo
Clinical-stage company developing phage therapies to target harmful bacteria.
United States of America
PHGE
BIONEERCORPORATION Logo
Develops and manufactures molecular biology products for research and diagnostics.
South Korea
064550
BioNTech SE Logo
Biotechnology company developing immunotherapies for cancer and infectious diseases.
United States of America
BNTX
BioPorto Logo
An in vitro diagnostics company specializing in biomarkers for early kidney injury detection.
Denmark
BIOPOR

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.